Asia Pacific Nasal Spray Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Asia Pacific Nasal Spray Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


  • Products Id :- DBMR749
  • |
  • Pages: 100
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Market Definition

Nasal sprays are the devices that help in the delivery of the drug through the nose in the nasal cavity to treat allergy and other problems related to brain inflammation, diabetes, dental problems, central nervous system. Allergy is a condition in which immune system of the body reacts abnormally to a foreign substance. Nasal spray drug products consist of therapeutically active ingredients or drug substances in the form of solution or suspension of excipients. There are different types of nasal spray available in the market such as decongestion nasal spray, saline nasal spray and steroid nasal spray. Decongestants are used to treat nasal congestion which provides short-term relief for a blocked or stuffy nose. Decongestion nasal spray comprises of drugs which shrinks the swollen membranes and open ups the airways of the nasal part which makes the breathing process easier.

Asia-Pacific nasal spray market is expected to reach with a healthy CAGR of 6.7% in the forecast period of 2018 to 2025. The new market report contains data for the historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation

By Product Type (Decongestion Nasal Spray, Steroid Nasal Spray, Salt Water Solution/Saline Nasal Spray, Others), Container Design (Pressurized Canisters, Pump Bottles), Dosage Form (Unit/Single Dose, Bi Dose, Multi Dose), Prescription Mode (Over the Counter, Prescription Based), Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), Application (Nasal Congestion, Allergic and Non-Allergic Rhinitis, Central Nervous System Disorders, Vaccination, Others), End User (Home Care Settings, Hospitals, Clinics, Community Health Care),Country (Japan, China, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, Philippines, Rest of Asia Pacific)

Major growing sectors under the market segmentation are as follows:

In product type, decongestion nasal spray segment is expected to dominate the global nasal spray market due to the rising problems associated with the decongestion of conditions such as colds & flu, hay fever, allergic reactions and sinusitis are helping the segment to grow in the forecast period of 2018 to 2025.

In therapeutic class, antihistamine segment is expected to dominate the market due to rising antihistamine usage amongst the population for different diseases such as congestion, runny nose, sneezing, itching, nasal swelling and different products availability by the companies is expected to dominate the market, whereas nasal steroids are available for both prescription and over the counter usage, and fast effective results are the major growth factors of the market.

In container design, pump bottles segment is expected to dominate the market due to the user friendly and wide offering of the over the counter products by the companies and it is expected to fuel the growth of pump bottles market in the forecast period. However, new advancement associated with the pressurized canisters.

In doses form, multi does segment is expected to dominate the market due to the wide availability in different dose volumes and user friendly attributes it is expected to drive the market of unit/single dose in the forecast period.

In prescription segment, prescription based segment is expected to dominate the market due to the rising chances of seasonal associated nasal problems and also for the various diseases such as pulmonary, dental anesthesia and others which leads the growth of prescription based segment is expected to fuel in the forecast period of 2018 to 2025.

In application segment, nasal congestion segment is expected to dominate the market due to the rising cases of nasal congestion diseases such as runny nose, sinus pain, mucus buildup and also availability of the over the counter products, nasal congestion segment is expected to dominate market. However, allergic and non-allergic rhinitis is the fastest growing segment among all because of the rising problems amongst the population such as antihistamines, nasal corticosteroids, hay fever and other, also seasonal imbalance is one of the reasons in raising the allergic and non-allergic rhinitis segment to grow in the forecast period with the highest CAGR.

The key market players for Asia-Pacific nasal spray market are listed below:

ADAPT Pharma, Inc.

Sandoz International GmbH

INNOVUS PHARMACEUTICALS, INC.

Cipla Inc.

Aurena

J Pharmaceuticals

Bayer AG

St. Renatus

ARIUS FORMULATIONS PVT LTD

Ultratech India Limited

GlaxoSmithKline plc

Egalet Corporation

LEEFORD HEALTHCARE LTD

Aishwarya Group



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

TABLE OF CONTENTS

1 INTRODUCTION 20

1.1 OBJECTIVES OF THE STUDY 20

1.2 MARKET DEFINITION 20

1.3 OVERVIEW OF NASAL SPRAY MARKET 21

1.4 CURRENCY AND PRICING 22

1.5 LIMITATION 22

1.6 MARKETS COVERED 22

2 MARKET SEGMENTATION 25

2.1 MARKETS COVERED 25

2.2 GEOGRAPHIC SCOPE 26

2.3 YEARS CONSIDERED FOR THE STUDY 27

2.4 CURRENCY AND PRICING 27

2.5 RESEARCH METHODOLOGY 28

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 31

2.7 SECONDARY SOURCES 32

2.8 ASSUMPTIONS 32

3 MARKET OVERVIEW 33

3.1 DRIVERS 35

3.1.1 IMPROVING PATIENT COMPLIANCE AND ACCEPTABILITY 35

3.1.2 EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY 36

3.1.3 INCREASE IN INFECTION & ALLERGIC CASES 37

3.2 RESTRAINTS 37

3.2.1 PRODUCT RECALLS 37

3.3 OPPORTUNITIES 38

3.3.1 NEW RISING DEMAND FOR SELF ADMINISTRATIVE DRUG DELIVERY 38

3.3.2 EXPANDING THERAPEUTIC APPLICATIONS FOR NASAL SPRAYS 38

3.4 CHALLENGES 39

3.4.1 REGULATORY HURDLES 39

4 EXECUTIVE SUMMARY 40

5 PREMIUM INSIGHTS 43

?

6 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT TYPE 46

6.1 OVERVIEW 47

6.2 DECONGESTION NASAL SPRAY 49

6.3 SALT WATER SOLUTION/ SALINE NASAL SPRAY 50

6.4 STEROID NASAL SPRAY 52

6.5 OTHERS 53

7 ASIA-PACIFIC N ASAL SPRAY MARKET, BY CONTAINER DESIGN 54

7.1 OVERVIEW 55

7.2 PRESSURIZED CANISTERS 57

7.3 PUMP BOTTLES 58

8 ASIA-PACIFIC NASAL SPRAY MARKET, BY DOSAGE FORM 59

8.1 OVERVIEW 60

8.2 UNIT/SINGLE DOSE 62

8.3 BI DOSE 64

8.4 MULTI DOSE 65

9 ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC CLASS 67

9.1 OVERVIEW 68

9.2 ANTIHISTAMINE 70

9.3 NASAL STEROIDS 72

9.4 MAST CELL INHIBITOR 73

9.5 ANTICHOLINERGIC 74

10 ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION 75

10.1 OVERVIEW 76

10.2 ALLERGIC AND NON-ALLERGIC RHINITIS 78

10.3 NASAL CONGESTION 80

10.4 CENTRAL NERVOUS SYSTEM DISORDERS 81

10.5 VACCINATION 82

10.6 OTHERS 83

11 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION MODE 84

11.1 OVERVIEW 85

11.2 PRESCRIPTION BASED 87

11.3 OVER THE COUNTER 88

?

12 ASIA-PACIFIC NASAL SPRAY MARKET, BY END USER 90

12.1 OVERVIEW 91

12.2 HOSPITALS 93

12.3 CLINICS 94

12.4 HOME CARE SETTINGS 95

12.5 COMMUNITY HEALTH CARE 96

13 ASIA-PACIFIC NASAL SPRAY MARKET, BY GEOGRAPHY 97

13.1 ASIA-PACIFIC 97

13.1.1 INCREAISNG PREVELENCE OF THE COPD 97

13.1.2 CHINA 106

13.1.3 JAPAN 110

13.1.4 INDIA 114

13.1.5 AUSTRALIA 118

13.1.6 SOUTH KOREA 122

13.1.7 MALAYSIA 126

13.1.8 THAILAND 130

13.1.9 SINGAPORE 134

13.1.10 INDONESIA 138

13.1.11 PHILIPPINES 142

13.1.12 REST OF ASIA PACIFIC 146

14 ASIA-PACIFIC NASAL SPRAY MARKET, COMPANY LANDSCAPE 147

14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 147

15 COMPANY PROFILE 148

15.1 PFIZER INC. 148

15.1.1 COMPANY OVERVIEW 148

15.1.2 REVENUE ANALYSIS 148

15.1.3 COMPANY SHARE ANALYSIS 149

15.1.4 PRODUCT PORTFOLIO 150

15.1.5 RECENT DEVELOPMENTS 150

15.2 CIPLA INC. 151

15.2.1 COMPANY OVERVIEW 151

15.2.2 REVENUE ANALYSIS 151

15.2.3 COMPANY SHARE ANALYSIS 152

15.2.4 PRODUCT PORTFOLIO 152

15.2.5 RECENT DEVELOPMENTS 153

?

15.3 BAYER AG 154

15.3.1 COMPANY OVERVIEW 154

15.3.2 REVENUE ANALYSIS 154

15.3.3 COMPANY SHARE ANALYSIS 155

15.3.4 PRODUCT PORTFOLIO 155

15.3.5 RECENT DEVELOPMENTS 155

15.4 INNOVUS PHARMACEUTICALS, INC. 156

15.4.1 COMPANY OVERVIEW 156

15.4.2 REVENUE ANALYSIS 156

15.4.3 COMPANY SHARE ANALYSIS 157

15.4.4 PRODUCT PORTFOLIO 157

15.4.5 RECENT DEVELOPMENTS 157

15.5 GLAXOSMITHKLINE PLC. 158

15.5.1 COMPANY OVERVIEW 158

15.5.2 REVENUE ANALYSIS 158

15.5.3 PRODUCT PORTFOLIO 159

15.5.4 RECENT DEVELOPMENTS 159

15.6 ADAPT PHARMA, INC. 160

15.6.1 COMPANY OVERVIEW 160

15.6.2 GEOGRAPHIC PRESENCE 160

15.6.3 PRODUCT PORTFOLIO 161

15.6.4 RECENT DEVELOPMENTS 161

15.7 AISHWARYA GROUP 162

15.7.1 COMPANY OVERVIEW 162

15.7.2 PRODUCT PORTFOLIO 162

15.7.3 RECENT DEVELOPMENTS 162

15.8 ALLERGAN 163

15.8.1 COMPANY OVERVIEW 163

15.8.2 REVENUE ANALYSIS 163

15.8.3 PRODUCT PORTFOLIO 163

15.8.4 RECENT DEVELOPMENTS 164

15.9 ARIUS FORMULATIONS PVT LTD 165

15.9.1 COMPANY OVERVIEW 165

15.9.2 PRODUCT PORTFOLIO 165

15.9.3 RECENT DEVELOPMENTS 165

15.10 AURENA 166

15.10.1 COMPANY OVERVIEW 166

15.10.2 GEOGRAPHIC PRESENCE 166

15.10.3 PRODUCT PORTFOLIO 167

15.10.4 RECENT DEVELOPMENTS 167

15.11 CATALENT, INC 168

15.11.1 COMPANY OVERVIEW 168

15.11.2 REVENUE ANALYSIS 168

15.11.3 PRODUCT PORTFOLIO 169

15.11.4 RECENT DEVELOPMENTS 169

15.12 EGALET CORPORATION 170

15.12.1 COMPANY OVERVIEW 170

15.12.2 REVENUE ANALYSIS 170

15.12.3 PRODUCT PORTFOLIO 171

15.12.4 RECENT DEVELOPMENTS 171

15.13 J PHARMACEUTICALS 172

15.13.1 COMPANY OVERVIEW 172

15.13.2 PRODUCT PORTFOLIO 172

15.13.3 RECENT DEVELOPMENTS 172

15.14 LEEFORD HEALTHCARE LTD 173

15.14.1 COMPANY OVERVIEW 173

15.14.2 GEOGRAPHIC PRESENCE 173

15.14.3 PRODUCT PORTFOLIO 174

15.14.4 RECENT DEVELOPMENTS 174

15.15 MYLAN N.V. 175

15.15.1 REVENUE ANALYSIS 175

15.15.2 PRODUCT PORTFOLIO 176

15.15.3 RECENT DEVELOPMENTS 176

15.16 SANDOZ INTERNATIONAL GMBH 177

15.16.1 COMPANY OVERVIEW 177

15.16.2 GEOGRAPHIC PRESENCE 177

15.16.3 PRODUCT PORTFOLIO 178

15.16.4 RECENT DEVELOPMENTS 178

15.17 ST. RENATUS 179

15.17.1 COMPANY OVERVIEW 179

15.17.2 PRODUCT PORTFOLIO 179

15.17.3 RECENT DEVELOPMENTS 179

15.18 TEVA PHARMACEUTICAL INDUSTRIES LTD. 180

15.18.1 COMPANY OVERVIEW 180

15.18.2 REVENUE ANALYSIS 180

15.18.3 PRODUCT PORTFOLIO 181

15.18.4 RECENT DEVELOPMENTS 181

?

15.19 ULTRATECH INDIA LIMITED 182

15.19.1 COMPANY OVERVIEW 182

15.19.2 PRODUCT PORTFOLIO 182

15.19.3 RECENT DEVELOPMENTS 182

16 RELATED REPORTS 183

LIST OF FIGURES

FIGURE 1 ASIA-PACIFIC NASAL SPRAY MARKET: SEGMENTATION 20

FIGURE 2 ASIA-PACIFIC NASAL SPRAY MARKET: DATA TRIANGULATION 23

FIGURE 3 ASIA-PACIFIC NASAL SPRAY MARKET: RESEARCH SNAPSHOT 24

FIGURE 4 ASIA-PACIFIC NASAL SPRAY MARKET:BOTTOM UP APPROACH 25

FIGURE 5 ASIA-PACIFIC NASAL SPRAY MARKET:TOP DOWN APPROACH 25

FIGURE 6 ASIA-PACIFICNASAL SPRAY MARKET: INTERVIEW DEMOGRAPHICS 26

FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC NASAL SPRAY MARKET 29

FIGURE 8 ASIA-PACIFIC NASAL SPRAY MARKET: SEGMENTATION 37

FIGURE 9 IMPROVING PATIENT COMPLIANCE AND ACCEPTIBILITY AND EFFECTIVENESS OVER OTHER FORMS OF DRUG DELIVERY ARE EXPECTED TO DRIVE THE MARKET FOR NASAL SPRAY IN THE FORECAST PERIOD 2018 TO 2025 38

FIGURE 10 DECONGESTION NASAL SPRAY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NASAL SPRAY MARKET IN 2018 & 2025 39

FIGURE 11 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR NASAL SPRAY MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025 40

FIGURE 12 ASIA-PACIFIC NASAL SPRAY MARKET: BY PRODUCT TYPE, 2017 42

FIGURE 13 ASIA-PACIFIC NASAL SPRAY MARKET: BY CONTAINER DESIGN, 2017 50

FIGURE 14 ASIA-PACIFIC NASAL SPRAY MARKET: BY DOSAGE FORM, 2017 55

FIGURE 15 ASIA-PACIFIC NASAL SPRAY MARKET: BY THERAPEUTIC CLASS, 2017 63

FIGURE 16 ASIA-PACIFIC NASAL SPRAY MARKET: BY APPLICATION, 2017 71

FIGURE 17 ASIA-PACIFIC NASAL SPRAY MARKET: BY PRESCRIPTION MODE, 2017 80

FIGURE 18 ASIA-PACIFIC NASAL SPRAY MARKET: BY END USER, 2017 86

FIGURE 19 ASIA PACIFIC NASAL SPRAY MARKET SNAPSHOT (2017) 93

FIGURE 20 ASIA PACIFIC NASAL SPRAY MARKET: BY COUNTRY (2017) 94

FIGURE 21 ASIA PACIFIC NASAL SPRAY MARKET: BY COUNTRY (2018 & 2025) 94

FIGURE 22 ASIA PACIFIC NASAL SPRAY MARKET: BY COUNTRY (2017 & 2025) 95

FIGURE 23 ASIA PACIFIC NASAL SPRAY MARKET: BY PRODUCT TYPE (2018-2025) 95

FIGURE 24 ASIA-PACIFIC NASAL SPRAY MARKET: COMPANY SHARE 2017 (%) 142

LIST OF TABLES

TABLE 1 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016 -2025, (USD MILLION) 43

TABLE 2 ASIA-PACIFIC DECONGESTION NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 44

TABLE 3 ASIA-PACIFIC SALT WATER SOLUTION/ SALINE NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 46

TABLE 4 ASIA-PACIFIC STEROID NASAL SPRAY IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025) 47

TABLE 5 ASIA-PACIFIC OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 48

TABLE 6 ASIA-PACIFIC NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016 -2025, (USD MILLION) 51

TABLE 7 ASIA-PACIFIC PRESSURIZED CANISTERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 52

TABLE 8 ASIA-PACIFIC PUMP BOTTLES IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 53

TABLE 9 ASIA-PACIFIC NASAL SPRAY MARKET, BY DOSAGE FORM, 2016 -2025, (USD MILLION) 56

TABLE 10 ASIA-PACIFIC UNIT/SINGLE DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 58

TABLE 11 ASIA-PACIFIC BI DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 59

TABLE 12 ASIA-PACIFIC MULTI-DOSE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 61

TABLE 13 ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016 -2025, (USD MILLION) 64

TABLE 14 ASIA-PACIFIC ANTIHISTAMINE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 66

TABLE 15 ASIA-PACIFIC NASAL STEROID IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 67

TABLE 16 ASIA-PACIFIC MAST CELL INHIBITOR IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 68

TABLE 17 ASIA-PACIFIC ANTICHOLINERGIC IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 69

TABLE 18 ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2016 -2025, (USD MILLION) 72

TABLE 19 ASIA-PACIFIC ALLERGIC AND NON-ALLERGIC RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 74

TABLE 20 ASIA-PACIFIC NASAL CONGESTION RHINITIS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 75

TABLE 21 ASIA-PACIFIC CENTRAL NERVOUS SYSTEM DISORDERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 76

TABLE 22 ASIA-PACIFIC VACCINATION IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 77

TABLE 23 ASIA-PACIFIC OTHERS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 78

TABLE 24 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016 -2025, (USD MILLION) 81

TABLE 25 ASIA-PACIFIC PRESCRIPTION BASED IN NASAL SPRAY MARKET, BY REGION, USD MILLION (2016 -2025) 82

TABLE 26 ASIA-PACIFIC OVER THE COUNTER BASED IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 84

TABLE 27 ASIA-PACIFIC NASAL SPRAY MARKET, BY END USER, 2016 -2025, (USD MILLION) 87

TABLE 28 ASIA-PACIFIC HOSPITALS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 88

TABLE 29 ASIA-PACIFIC CLINICS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 89

TABLE 30 ASIA-PACIFIC HOME CARE SETTINGS IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 90

TABLE 31 ASIA-PACIFIC COMMUNITY HEALTH CARE IN NASAL SPRAY MARKET, BY REGION, 2016 -2025, (USD MILLION) 91

TABLE 32 ASIA-PACIFIC NASAL SPRAY MARKET, BY COUNTRY, 2016-2025, (USD MILLION) 96

TABLE 33 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 97

TABLE 34 ASIA-PACIFIC NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 97

TABLE 35 ASIA-PACIFIC NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 98

TABLE 36 ASIA-PACIFIC NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 98

TABLE 37 ASIA-PACIFIC NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 99

TABLE 38 ASIA-PACIFIC NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 99

TABLE 39 ASIA-PACIFIC NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 100

TABLE 40 CHINA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 101

TABLE 41 CHINA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 101

TABLE 42 CHINA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 102

TABLE 43 CHINA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 102

TABLE 44 CHINA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 103

TABLE 45 CHINA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 103

TABLE 46 CHINA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 104

TABLE 47 U.K. NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 105

TABLE 48 JAPAN NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 105

TABLE 49 JAPAN NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 106

TABLE 50 JAPAN NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 106

TABLE 51 JAPAN NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 107

TABLE 52 JAPAN NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 107

TABLE 53 JAPAN NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 108

TABLE 54 INDIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 109

TABLE 55 INDIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 109

TABLE 56 INDIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 110

TABLE 57 INDIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 110

TABLE 58 INDIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 111

TABLE 59 INDIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 111

TABLE 60 INDIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 112

TABLE 61 AUSTRALIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 113

TABLE 62 AUSTRALIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 113

TABLE 63 AUSTRALIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 114

TABLE 64 AUSTRALIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 114

TABLE 65 AUSTRALIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 115

TABLE 66 AUSTRALIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 115

TABLE 67 AUSTRALIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 116

TABLE 68 SOUTH KOREA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 117

TABLE 69 SOUTH KOREA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 117

TABLE 70 SOUTH KOREA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 118

TABLE 71 SOUTH KOREA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 118

TABLE 72 SOUTH KOREA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 119

TABLE 73 SOUTH KOREA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 119

TABLE 74 SOUTH KOREA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 120

TABLE 75 MALAYSIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 121

TABLE 76 MALAYSIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 121

TABLE 77 MALAYSIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 122

TABLE 78 MALAYSIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 122

TABLE 79 MALAYSIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 123

TABLE 80 MALAYSIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 123

TABLE 81 MALAYSIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 124

TABLE 82 THAILAND NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 125

TABLE 83 THAILAND NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 125

TABLE 84 THAILAND NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 126

TABLE 85 THAILAND NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 126

TABLE 86 THAILAND NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 127

TABLE 87 THAILAND NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 127

TABLE 88 THAILAND NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 128

TABLE 89 SINGAPORE NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 129

TABLE 90 SINGAPORE NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 129

TABLE 91 SINGAPORE NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 130

TABLE 92 SINGAPORE NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 130

TABLE 93 SINGAPORE NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 131

TABLE 94 SINGAPORE NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 131

TABLE 95 SINGAPORE NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 132

TABLE 96 INDONESIA NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 133

TABLE 97 INDONESIA NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 133

TABLE 98 INDONESIA NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 134

TABLE 99 INDONESIA NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 134

TABLE 100 INDONESIA NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 135

TABLE 101 INDONESIA NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 135

TABLE 102 INDONESIA NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 136

TABLE 103 PHILIPPINES NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 137

TABLE 104 PHILIPPINES NASAL SPRAY MARKET, BY CONTAINER DESIGN, 2016-2025, (USD MILLION) 137

TABLE 105 PHILIPPINES NASAL SPRAY MARKET, BY DOSAGE FORM, 2016-2025, (USD MILLION) 138

TABLE 106 PHILIPPINES NASAL SPRAY MARKET, BY THERAPEUTIC CLASS, 2016-2025, (USD MILLION) 138

TABLE 107 PHILIPPINES NASAL SPRAY MARKET, BY APPLICATION, 2016-2025, (USD MILLION) 139

TABLE 108 PHILIPPINES NASAL SPRAY MARKET, BY PRESCRIPTION MODE, 2016-2025, (USD MILLION) 139

TABLE 109 PHILIPPINES NASAL SPRAY MARKET, BY END USER, 2016-2025, (USD MILLION) 140

TABLE 110 REST OF ASIA-PACIFIC NASAL SPRAY MARKET, BY PRODUCT TYPE, 2016-2025, (USD MILLION) 141

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

ADAPT Pharma, Inc.

Sandoz International GmbH

INNOVUS PHARMACEUTICALS, INC.

Cipla Inc.

Aurena

J Pharmaceuticals

Bayer AG

St. Renatus

ARIUS FORMULATIONS PVT LTD

Ultratech India Limited

GlaxoSmithKline plc

Egalet Corporation

LEEFORD HEALTHCARE LTD

Aishwarya Group

select a license
Single User License
USD 2500 INR 179750
Corporate User License
USD 3200 INR 230080

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com